IRadimed Corporation (NASDAQ:IRMD ) Q4 2022 Earnings Conference Call February 2, 2023 11:00 AM ET Company Participants Roger Susi - President & CEO Jack Glenn – CFO Conference Call Participants Scot
iRadimed (IRMD) possesses solid growth attributes, which could help it handily outperform the market.
WINTER SPRINGS, Fla., Jan. 18, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced selected preliminary financial results for the fourth quarter that end

Cigna (CI) Focuses on Enhancing Pharmacy Offerings in 2023

06:22pm, Tuesday, 06'th Dec 2022 Zacks Investment Research
Cigna (CI) decides to integrate cost-effective biosimilars within its commercial formularies from next year in a bid to drive pharmacy revenues.

Here is Why Growth Investors Should Buy iRadimed (IRMD) Now

05:45pm, Tuesday, 29'th Nov 2022 Zacks Investment Research
iRadimed (IRMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
iRadimed (IRMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
ShockWave Medical, iRadimed and Tactile Systems Technology are part of the Zacks top Analyst Blog.

3 Medical Instruments Stocks With Potential to Outperform

01:27pm, Monday, 28'th Nov 2022 Zacks Investment Research
Here we discuss ShockWave Medical (SWAV), iRadimed (IRMD) and Tactile Systems Technology (TCMD), which have the potential to outperform their industry going forward.
Here we discuss ShockWave Medical (SWAV), iRadimed (IRMD) and Tactile Systems Technology (TCMD), which have the potential to outperform their industry going forward.
IRadimed Corporation continues to re-rate to the downside despite robust fundamentals last quarter. Despite this, the market may have discounted the stock correctly looking at revenue, EPS estimates i
IRadimed Corporation (NASDAQ:IRMD ) Q3 2022 Earnings Conference Call November 3, 2022 11:00 AM ET Company Participants Roger Susi - President and Chief Executive Officer Jack Glenn - Chief Financial O
Announces Preliminary Financial Results for Third Quarter 2022 Announces Preliminary Financial Results for Third Quarter 2022
WINTER SPRINGS, Fla., Oct. 06, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced the appointment of Hilda Scharen-Guivel to the Iradimed Board of Dire
Snowflake Inc. (NYSE: SNOW) surged 17.4% to $187.18 in pre-market trading after the company reported better-than-expected Q2 sales results and issued product revenue guidance. FREYR Battery (NYSE: FRE

3 Healthcare Stocks With High Profit Margins

09:13am, Wednesday, 10'th Aug 2022 The Motley Fool
If you want to invest in profitable healthcare companies in this bear market, these all look like good bets.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE